Enhancers in embryonic stem cells are enriched for transposable elements and genetic variations associated with cancers.
about
Enrichment analysis of Alu elements with different spatial chromatin proximity in the human genomeMammalian-wide interspersed repeat (MIR)-derived enhancers and the regulation of human gene expressionEP-DNN: A Deep Neural Network-Based Global Enhancer Prediction AlgorithmChromatin states reveal functional associations for globally defined transcription start sites in four human cell lines.Transcriptome-wide Investigation of mRNA/circRNA in miR-184 and Its r.57c > u Mutant Type Treatment of Human Lens Epithelial Cells.On the identification of potential regulatory variants within genome wide association candidate SNP sets.Enhancers as information integration hubs in development: lessons from genomics.Cancer genetics and epigenetics: two sides of the same coin?RFECS: a random-forest based algorithm for enhancer identification from chromatin state.TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells.Genome-Wide Detection of Gene Coexpression Domains Showing Linkage to Regions Enriched with Polymorphic Retrotransposons in Recombinant Inbred Mouse Strains.Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.How do mammalian transposons induce genetic variation? A conceptual framework: the age, structure, allele frequency, and genome context of transposable elements may define their wide-ranging biological impacts.Transcription factor binding at enhancers: shaping a genomic regulatory landscape in flux.Integrative Analysis of Transcription Factor Combinatorial Interactions Using a Bayesian Tensor Factorization Approach.
P2860
Q28601408-4AD9D409-BC6B-4802-A9C3-150C380C2E60Q28655902-613B1F2D-1760-4C92-84DB-4790D50420C9Q30367835-76ED7F91-EB39-44D9-92F6-FEB659C99B34Q31154613-D8B872A7-D51A-4AC7-8598-1DF4514D8DF9Q33635320-64D5928D-2AE8-4694-A9A8-EA8BAFAA49F0Q33789149-558119E0-920B-4F34-94F2-7D9D2E1BBB6AQ34266848-421A228E-089C-4C8A-8E30-2A8A043D5183Q34287662-89B38D30-49EF-4302-B44C-2B2425B27042Q34633894-AFD6E8F6-CD86-4871-8615-2776C598660EQ36660136-034E2523-1286-4F05-AE9C-FA07BDCD9330Q36744909-8056641B-377A-4DB2-B3ED-486C35414F11Q38185270-C4B56BCD-B979-4287-A3DF-41F4A061F875Q42095539-9176138E-65AE-42CA-B64F-30254A878C22Q42106622-FEA37F95-EB93-47A5-9BE2-C354C0B9FB47Q42369126-3667CFF9-0CBF-4D8B-B60A-7C1A2E129602
P2860
Enhancers in embryonic stem cells are enriched for transposable elements and genetic variations associated with cancers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhancers in embryonic stem ce ...... tions associated with cancers.
@ast
Enhancers in embryonic stem ce ...... tions associated with cancers.
@en
type
label
Enhancers in embryonic stem ce ...... tions associated with cancers.
@ast
Enhancers in embryonic stem ce ...... tions associated with cancers.
@en
prefLabel
Enhancers in embryonic stem ce ...... tions associated with cancers.
@ast
Enhancers in embryonic stem ce ...... tions associated with cancers.
@en
P2093
P2860
P356
P1476
Enhancers in embryonic stem ce ...... tions associated with cancers.
@en
P2093
P2860
P304
P356
10.1093/NAR/GKR476
P407
P577
2011-06-17T00:00:00Z